ℹ️
🇬🇧
Search
Search for people relevant for "PlGF"
PlGF
Person
Class
Person
Publication
Programmes
MUDr. Tomáš Doležal Ph.D.
Academic staff at Third Faculty of Medicine
81 publications
Publications
publication
BIOREP - Biologic/Targeted Therapy Registry: 2022 Summary Report
2023 |
Third Faculty of Medicine, First Faculty of Medicine, Central Library of Charles University, Faculty of Medicine in Pilsen
publication
Dupilumab for the treatment of atopic dermatitis: Real-world data from the Czech Republic BIOREP registry
2022 |
Third Faculty of Medicine, First Faculty of Medicine, Central Library of Charles University, Faculty of Medicine in Pilsen
publication
Efficacy, safety, and drug survival of patients with psoriasis treated with IL-17 inhibitors - brodalumab, ixekizumab, and secukinumab: real-world data from the Czech Republic BIOREP registry
2022 |
Third Faculty of Medicine, First Faculty of Medicine, Central Library of Charles University, Faculty of Medicine in Pilsen
publication
Efficacy of switches within the class of IL-17 inhibitors: An analysis of data from the Czech nationwide registry of psoriatic patients receiving biological/targeted therapy (BIOREP)
2022 |
Third Faculty of Medicine, First Faculty of Medicine, Central Library of Charles University, Faculty of Medicine in Pilsen
publication
Registry of Biological/Targeted Therapy BIOREP - Summary Report 2021
2022 |
Third Faculty of Medicine, First Faculty of Medicine, Central Library of Charles University, Faculty of Medicine in Pilsen
publication
Direct costs in patients with nonvalvular atrial fibrillation newly indicated to apixaban: a retrospective-prospective single-arm cohort study
2022 |
Third Faculty of Medicine, First Faculty of Medicine, Central Library of Charles University
publication
Real-life experience in the effectiveness, impact on quality of life and safety of dupilumab treatment in patients with moderate to severe atopic dermatitis in the Czech Republic
2022 |
Third Faculty of Medicine, First Faculty of Medicine, Central Library of Charles University
publication
Risankizumab for the Treatment of Moderate-to-Severe Psoriasis: Real-Life Multicenter Experience from the Czech Republic
2021 |
Third Faculty of Medicine, First Faculty of Medicine, Central Library of Charles University, Faculty of Medicine in Pilsen
publication
Efficacy of biological treatment of moderate to severe psoriasis - analysis from the BIOREP Registry
2021 |
Third Faculty of Medicine, First Faculty of Medicine, Central Library of Charles University, Faculty of Medicine in Pilsen
publication
Atopic Dermatitis in the BIOREP Registry
2021 |
Third Faculty of Medicine, First Faculty of Medicine, Central Library of Charles University, Faculty of Medicine in Pilsen
Load more publications (71)
Loading network view...